[Correspondence] 12-month persistence of immune responses to self-amplifying mRNA COVID-19 vaccines: ARCT-154 versus BNT162b2 vaccine
COVID-19 is no longer a global pandemic but remains a public health problem and new vaccine formulations are still being developed to target newly emerging variants.1 Current guidelines recommend annual vaccination for all people older than 50 years an...